MedPath

Takeda Pharmaceutical Company Ltd

🇯🇵Japan
Ownership
-
Established
1925-01-01
Employees
-
Market Cap
$47.5B
Website
http://www.takeda.co.jp/

A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

Phase 4
Completed
Conditions
Central Precocious Puberty
Interventions
First Posted Date
2022-04-22
Last Posted Date
2025-05-16
Lead Sponsor
Takeda
Target Recruit Count
80
Registration Number
NCT05341115
Locations
🇨🇳

Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

the First A liated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

🇨🇳

The Hospital attached by the Torigji Medical College, Huazhong Science and Technology University., Wuhan, Hubei, China

and more 2 locations

A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China

Recruiting
Conditions
Central Precocious Puberty
First Posted Date
2022-04-22
Last Posted Date
2025-05-18
Lead Sponsor
Takeda
Target Recruit Count
1000
Registration Number
NCT05341128
Locations
🇨🇳

The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

🇨🇳

Hainan Women and Children's Medical Center, Haikou, Hainan, China

🇨🇳

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei, China

and more 2 locations

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Phase 3
Active, not recruiting
Conditions
Cytomegalovirus (CMV)
Interventions
First Posted Date
2022-04-08
Last Posted Date
2024-12-10
Lead Sponsor
Takeda
Target Recruit Count
80
Registration Number
NCT05319353
Locations
🇧🇷

Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil

🇧🇷

Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre, Rio Grande Do Sul, Brazil

🇧🇷

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Porto Alegre, Rio Grande Do Sul, Brazil

and more 44 locations

A Survey of Midazolam in People With Status Epilepticus

Recruiting
Conditions
Epilepsy
Interventions
First Posted Date
2022-04-06
Last Posted Date
2025-05-11
Lead Sponsor
Takeda
Target Recruit Count
50
Registration Number
NCT05313308
Locations
🇯🇵

Takeda selected site, Tokyo, Japan

Virtual Celiac Symptoms Study in Adults and Teenagers

Completed
Conditions
Celiac Disease
Interventions
Other: No Intervention
First Posted Date
2022-04-04
Last Posted Date
2023-03-10
Lead Sponsor
Takeda
Target Recruit Count
480
Registration Number
NCT05309330
Locations
🇺🇸

Takeda, Lexington, Massachusetts, United States

A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

Phase 1
Withdrawn
Conditions
Healthy Volunteers
Interventions
First Posted Date
2022-04-04
Last Posted Date
2022-11-14
Lead Sponsor
Takeda
Registration Number
NCT05309902

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Phase 3
Completed
Conditions
Coronavirus Disease (COVID-19)
Interventions
First Posted Date
2022-03-29
Last Posted Date
2024-10-21
Lead Sponsor
Takeda
Target Recruit Count
150
Registration Number
NCT05299359
Locations
🇯🇵

PS Clinic, Fukuoka, Japan

🇯🇵

Sumida Hospital, Sumida-ku, Tokyo, Japan

A Study of Chinese Adults With Lymphoma

Completed
Conditions
Lymphoma
First Posted Date
2022-03-21
Last Posted Date
2024-08-12
Lead Sponsor
Takeda
Target Recruit Count
934
Registration Number
NCT05288491
Locations
🇨🇳

Jiangsu Province Hospital, Nanjing, Jiangsu, China

🇨🇳

Shanxi Cancer Hospital, Taiyuan, Shanxi, China

🇨🇳

Tongji Medical College of Hust, Wuhan, Hubei, China

and more 16 locations

A Study of Soticlestat Tablets in Healthy Adults

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2022-03-17
Last Posted Date
2024-02-28
Lead Sponsor
Takeda
Target Recruit Count
96
Registration Number
NCT05284760
Locations
🇺🇸

Celerion, Tempe, Arizona, United States

A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

Completed
Conditions
Drug Hypersensitivity
Interventions
Other: No intervention
First Posted Date
2022-03-07
Last Posted Date
2022-09-23
Lead Sponsor
Takeda
Target Recruit Count
72
Registration Number
NCT05269082
Locations
🇺🇸

PPD, Wilmington, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath